The company hopes this new round of funding from private-equity investors will help its home-based care model flourish and reach more patients than ever before. 

Even as TAVR continues to build momentum as the go-to treatment option for many patients, researchers are keeping a close eye on the long-term safety and effectiveness of SAVR.

The new healthcare facility is the first of its kind, offering same-day cardiac imaging scans, cardiologist consultations and diagnoses. 

The agency said Abiomed did not seek the necessary approvals for one Impella-related device and was slow to act on certain safety concerns. 

The American Heart Association has developed an updated strategy for the prevention and management of cardiovascular disease. A newly defined health condition, cardiovascular-kidney-metabolic syndrome, sits at the center of that strategy. 

Post-TAVR stroke is rare, but it can be fatal. A new study in Catheterization and Cardiovascular Interventions examined the issue in great detail, focusing on more than 2,700 patients treated over a two-year stretch. 

The group's roster of 17 like-minded cardiology practices now has access to MedAxiom's practice management tools and other key resources. 

The free webinar, scheduled for Sept. 29, will examine the benefits of using CCTA and FFR-CT to manage chest pain patients.